Just 18% of people who have had kidney transplants develop antibody responses to COVID-19 vaccines

A new study from Rouen Hospital in France found that after two doses of Pfizer's vaccine, 88.9% of dialysis patients developed antibodies against the virus compared to 17.8% of transplant recipients.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news